CTI BioPharma’s confirmatory trial of Pixuvri in lymphoma fails

The EMA required the PIX306 as a confirmatory trial for conditional approval, while CTI considered potentially using it to pursue FDA approval.

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button